SynCardia Awards and Recognition
Medical Device and Diagnostic Industry (MD+DI)
On June 19, SynCardia's Companion 2 (C2) Driver System, which powers the SynCardia temporary Total Artificial Heart in the hospital, was selected as the Silver Winner in the Critical-Care and Emergency Medicine Products category of the 15th Annual Medical Design Excellence Awards (MDEA) in Philadelphia.
SynCardia's Freedom® Portable Driver
Selected as Silver Winner
On April 25, SynCardia's Freedom® portable driver, the world's first wearable power supply for the SynCardia temporary Total Artificial Heart, was named the 2013 Silver Winner amongst Assistive Devices in the Science/Medical category of the Edison Awards. The Edison Awards honor game-changing innovations that are at the forefront of new product and service development, marketing and human-centered design, and are one of the highest accolades a company can receive in the name of successful innovation.
Medical Device and Diagnostic Industry (MD+DI)
In April, SynCardia's Companion 2 (C2) Driver System, which powers the SynCardia temporary Total Artificial Heart in the hospital, was selected as one of four finalists in the Critical-Care and Emergency Medicine Products category of the 15th Annual Medical Design Excellence Awards (MDEA). The winners will be announced on June 19 in Philadelphia.
SynCardia Ranked Among "America's Most Promising Companies"
for Second Straight Year
In its February issue, Forbes selected SynCardia as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was ranked #69, moving up eight spots from its #77 ranking last year.
SynCardia Honored with Innovation in the Workplace Award
Society for Human Resource Management of Greater Tucson (SHRM-GT)
On March 12, SynCardia was honored with an Innovation in the Workplace Award for its internship program. The honorees were chosen from 20 individuals and 11 companies that were finalists. More than 50 people and companies were nominated for the awards.
Copper Cactus Awards
On Nov. 13, 2012, SynCardia was announced the winner of the Nextrio Innovation through Technology Award for its Freedom portable driver as part of the Copper Cactus Awards presented by the Tucson Chamber of Commerce.
SynCardia Wins Two "Best in Biz" Awards
Product of the Year: Gold Winner (Freedom portable driver)
Executive of the Year: Silver Winner (Michael Garippa)
Best in Biz Awards
On Nov. 12, 2012, SynCardia was honored with two Best in Biz Awards. The Freedom portable driver was selected as the Gold winner for "Product of the Year" and SynCardia Chairman/CEO/President Michael Garippa was honored as the Silver winner for "Executive of the Year."
Winners were selected from more than 400 entries by an independent panel of 32 judges from top-tier news, business and technology publications, broadcast outlets and analyst firms, including ABC, Businessweek, Entrepreneur, Forbes, FOX News and USA Today.
SynCardia Honored with Two Gold Stevie® Awards
"Company of the Year – Health Products & Services"
"Most Innovative Company of the Year – up to 100 Employees"
2012 American Business Awards
On June 18, 2012, SynCardia Systems, Inc. was honored with two Gold Stevie® Awards at the 10th Annual American Business Awards. SynCardia won "Company of the Year – Health Products and Services" and "Most Innovative Company of the Year – up to 100 Employees."
Medical Device and Diagnostic Industry (MD+DI)
On May 23, 2012, the Freedom® portable driver was selected as the Bronze Winner in the Critical Care and Emergency Medicine category of the 2012 Medical Design Excellence Awards (MDEA) in Philadelphia. MDEA entries were evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability to overcome design and engineering challenges to meet clinical objectives.
On May 9, 2012, the TechAmerica Foundation announced the finalists for the 2012 American Technology Awards (Termans), which recognize technology products and services across the technology industry. SynCardia's Freedom® portable driver was named one of four finalists in the Health and Medical Technologies category.
MEDTEC European Medical Device Technology (EMDT)
On Jan. 23, 2012, SynCardia was notified that its Freedom® portable driver, the world's first wearable power supply for the SynCardia temporary Total Artificial Heart, has been shortlisted for "Most Innovative Cardiac Product of the Year" as part of the MEDTEC European Medical Device Technology (EMDT) Innovation Awards. The Awards are the only European awards dedicated to recognizing achievements in the medical device sector.
In its December issue, Forbes selected SynCardia as one of "America's Most Promising Companies." The list features 100 privately held up-and-comers with compelling business models, strong management teams, notable customers, strategic partners and precious investment capital. Ranked No. 77, SynCardia was the only Arizona company to make the cut.
SynCardia Named #20 Among
"World's Most Innovative Companies"
Fast Company Magazine
In its March issue, Fast Company magazine named SynCardia #20 in its annual list of the World's 50 Most Innovative Companies. Described as a "rising newcomer," SynCardia was recognized for "giving mobility to artificial heart recipients” and joined major brands including Apple, Twitter, Google and Intel in the Top 50. SynCardia designed, developed and introduced the new Freedom® portable driver, the world’s first wearable power supply for the Total Artificial Heart.
SynCardia Selected as Finalist for
2011 World Technology Award
World Technology Network (WTN) in association with TIME, Fortune, CNN, Science/AAAS and Technology Review
In September 2011, SynCardia was selected as one of six finalists for the 2011 World Technology Award in Health and Medicine. The award, which honors those doing "innovative work of the greatest likely long-term significance" in science, technology and related fields, was presented by WTN in association with TIME, Fortune, CNN, Science/AAAS and Technology Review.
“Arizona Bioscience Company of the Year”
Arizona BioIndustry Association (AZBio)
On Oct. 13, 2011, SynCardia was named "Arizona Bioscience Company of the Year" by the Arizona BioIndustry Association (AZBio). The award recognizes the for-profit bioscience company whose Arizona-based operations did the most to transform the world during the last 12 months.
According to AZBio CEO Joan Koerber-Walker, "SynCardia makes it possible for patients awaiting donor hearts to not only survive the wait but also to do so with flexibility and mobility, a feat of biomedical engineering that is world-changing for these patients."
SynCardia CFO Dena Richter Selected as a
Finalist for “CFO of the Year”
Financial Executives International
In November 2011, SynCardia’s CFO Dena Richter was selected as a finalist for “Private Company CFO of the Year” by Financial Executives International (FEI). The CFO of the Year Awards are given to professionals for outstanding performance in their roles as corporate financial stewards.
SynCardia’s Total Artificial Heart Wins
2010 Kerrin Rennie Award for Excellence
in Medical Technology
Medical Technology Association of Australia (MTAA)
On Sept. 15, 2010, the SynCardia temporary Total Artificial Heart was awarded the 2010 Kerrin Rennie Award for Excellence in Medical Technology by the Medical Technology Association of Australia (MTAA). The Kerrin Rennie Award recognizes the innovative and extraordinary contribution of medical technology in improving health outcomes of Australian patients. St. Vincent's Hospital in Sydney made headlines in August 2010 when it performed the Southern Hemisphere's first implant of the Total Artificial Heart. It was followed by a second implant less than two weeks later.
SynCardia Named Among
50 Companies to Watch for 2010
Medical Device and Diagnostic Industry (MD+DI) Magazine
In June 2010, Medical Device and Diagnostic Industry (MD+DI) magazine selected SynCardia as one of 50 Companies to Watch for 2010. MD+DI selected SynCardia because: “The SynCardia Total Artificial Heart is the only device of its kind with regulatory approval in the United States, Canada, and Europe. The device, meant for people dying from end-stage biventricular failure, works similar to a heart transplant in that it replaces both the right and left heart ventricles. Plus, there’s no waiting list like there is for donor hearts (the company has certified centers set up throughout the world).”
SynCardia's Total Artificial Heart Featured Among 100 Most Important Events in Human History
Mathers Museum of World Cultures
at Indiana University (IU)
On Oct. 23, 2010, a new exhibit featuring the SynCardia temporary Total Artificial Heart titled "From the Big Bang to the World Wide Web: The Origins of Everything," opened at the Mathers Museum of World Cultures at Indiana University (IU). The exhibit revolves around the 100 most important events in the "evolution of everything," including human, biological and planetary history.
"In the field of medical devices, the Total Artificial Heart represents life-saving technological innovation and remarkable scientific progress," said Kathy Schick, one of two IU anthropology professors who produced the long-term exhibit.